To evaluate the prognostic value of surem TRAF3IP2 levels in patients with acute myocardial infarction
Previous study had concluded that TRAF3IP2 plays a causal role in atherosclerotic plaque development and vulnerability in mice. However, no human data was available. In the present study, patients diagnosed with acute myocardial infarction who receive coronary angiography will be enrolled. Their surem TRAF3IP2 levels will be tested using ELASA. The association of surem TRAF3IP2 levels with the major adverse cardiac events will be evaluated.
Study Type
OBSERVATIONAL
Enrollment
200
This is an obvertional study, and there is no intervention.
Huai'an First People's Hospital
Huai'an, Jiangsu, China
RECRUITINGMACEs (major adverse cardiac events)
MACEs were defined as a composite of cardiac death, hospitalization for myocardial infarction or heart failure
Time frame: 1 year
cardiac death
and death due to cardiac reasons, such as myocardial infarction or heart failure
Time frame: 1 year
hospitalization for myocardial infarction or heart failure
hospitalization for myocardial infarction or heart failure
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.